{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:17:02Z","timestamp":1782839822747,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T00:00:00Z","timestamp":1531094400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12882-018-0959-5","type":"journal-article","created":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T09:32:30Z","timestamp":1531128750000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Determinants of hyperuricemia in non-dialysed chronic kidney disease patients in three hospitals in Cameroon"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6296-517X","authenticated-orcid":false,"given":"Marie","family":"Doualla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Patrice","family":"Halle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jude","family":"Moutchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Tegang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Ashuntantang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,9]]},"reference":[{"issue":"3","key":"959_CR1","doi-asserted-by":"publisher","first-page":"e174-e181","DOI":"10.1016\/S2214-109X(14)70002-6","volume":"2","author":"JW Stanifer","year":"2014","unstructured":"Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S, Patel U. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(3):e174-e181.","journal-title":"Lancet Glob Health"},{"issue":"Suppl 1","key":"959_CR2","first-page":"S13","volume":"74","author":"S Naicker","year":"2010","unstructured":"Naicker S. Burden of end-stage renal disease in sub-Saharan Africa. Clin Nephrol. 2010;74(Suppl 1):S13\u20136.","journal-title":"Clin Nephrol"},{"issue":"1","key":"959_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s41100-016-0021-7","volume":"2","author":"JB Wetmore","year":"2016","unstructured":"Wetmore JB, Collins AJ. Global challenges posed by the growth of end-stage renal disease. Ren Replace Ther. 2016;2(1):15.","journal-title":"Ren Replace Ther"},{"key":"959_CR4","doi-asserted-by":"crossref","unstructured":"Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975\u201382.","DOI":"10.1016\/S0140-6736(14)61601-9"},{"issue":"1","key":"959_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12882-015-0111-8","volume":"16","author":"FF Kaze","year":"2015","unstructured":"Kaze FF, Meto DT, Halle M-P, Ngogang J, Kengne A-P. Prevalence and determinants of chronic kidney disease in rural and urban Cameroonians: a cross-sectional study. BMC Nephrol. 2015;16(1):117.","journal-title":"BMC Nephrol"},{"issue":"1","key":"959_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12882-016-0377-5","volume":"17","author":"MP Halle","year":"2016","unstructured":"Halle MP, Ashuntantang G, Kaze FF, Takongue C, Kengne A-P. Fatal outcomes among patients on maintenance haemodialysis in sub-Saharan Africa: a 10-year audit from the Douala general Hospital in Cameroon. BMC Nephrol. 2016;17(1):165.","journal-title":"BMC Nephrol"},{"key":"959_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.11604\/pamj.2017.26.97.9658","volume":"26","author":"H Fouda","year":"2017","unstructured":"Fouda H, Ashuntantang G, Kaze F, Halle M-P. Survival among chronic hemodialysed patient in Cameroon. Pan Afr Med J. 2017;26:97.","journal-title":"Pan Afr Med J"},{"issue":"3","key":"959_CR8","doi-asserted-by":"publisher","first-page":"e124-e125","DOI":"10.1016\/S2214-109X(14)70014-2","volume":"2","author":"N Perico","year":"2014","unstructured":"Perico N, Remuzzi G. Chronic kidney disease in sub-Saharan Africa: a public health priority. Lancet Glob Health. 2014;2(3):e124-e125.","journal-title":"Lancet Glob Health"},{"issue":"3","key":"959_CR9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1053\/j.ajkd.2007.12.006","volume":"51","author":"FA Arogundade","year":"2008","unstructured":"Arogundade FA, Barsoum RS. CKD prevention in sub-Saharan Africa: a call for governmental, nongovernmental, and community support. Am J Kidney Dis. 2008;51(3):515\u201323.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"959_CR10","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3109\/0886022X.2011.653753","volume":"34","author":"V Filiopoulos","year":"2012","unstructured":"Filiopoulos V, Hadjiyannakos D, Vlassopoulos D. New insights into uric acid effects on the progression and prognosis of chronic kidney disease. Ren Fail. 2012;34(4):510\u201320.","journal-title":"Ren Fail"},{"issue":"10","key":"959_CR11","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1038\/sj.ki.5000391","volume":"69","author":"T Nakagawa","year":"2006","unstructured":"Nakagawa T, Kang DH, Feig D, Sanchez-Lozada LG, Srinivas TR, Sautin Y, Ejaz AA, Segal M, Johnson RJ. Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease. Kidney Int. 2006;69(10):1722\u20135.","journal-title":"Kidney Int"},{"issue":"1","key":"959_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1053\/j.ajkd.2012.07.021","volume":"61","author":"DI Jalal","year":"2013","unstructured":"Jalal DI, Chonchol M, Chen W, Targher G. Uric acid as a target of therapy in CKD. Am J Kidney Dis. 2013;61(1):134\u201346.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"959_CR13","doi-asserted-by":"publisher","first-page":"e0170393","DOI":"10.1371\/journal.pone.0170393","volume":"12","author":"C-W Tsai","year":"2017","unstructured":"Tsai C-W, Lin S-Y, Kuo C-C, Huang C-C. Serum uric acid and progression of kidney disease: a longitudinal analysis and mini-review. PLoS One. 2017;12(1):e0170393.","journal-title":"PLoS One"},{"issue":"2","key":"959_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/j.ajkd.2007.05.013","volume":"50","author":"M Chonchol","year":"2007","unstructured":"Chonchol M, Shlipak MG, Katz R, Sarnak MJ, Newman AB, Siscovick DS, Kestenbaum B, Carney JK, Fried LF. Relationship of uric acid with progression of kidney disease. Am J Kidney Dis. 2007;50(2):239\u201347.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"959_CR15","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1093\/ndt\/gfr561","volume":"27","author":"N Altemtam","year":"2012","unstructured":"Altemtam N, Russell J, El Nahas M. A study of the natural history of diabetic kidney disease (DKD). Nephrol Dial Transplant. 2012;27(5):1847\u201354.","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"959_CR16","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0929-6646(10)60004-6","volume":"108","author":"CJ Yen","year":"2009","unstructured":"Yen CJ, Chiang CK, Ho LC, Hsu SH, Hung KY, Wu KD, Tsai TJ. Hyperuricemia associated with rapid renal function decline in elderly Taiwanese subjects. J Formos Med Assoc. 2009;108(12):921\u20138.","journal-title":"J Formos Med Assoc"},{"issue":"6","key":"959_CR17","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.2337\/dc10-0227","volume":"33","author":"LH Ficociello","year":"2010","unstructured":"Ficociello LH, Rosolowsky ET, Niewczas MA, Maselli NJ, Weinberg JM, Aschengrau A, Eckfeldt JH, Stanton RC, Galecki AT, Doria A, et al. High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up. Diabetes Care. 2010;33(6):1337\u201343.","journal-title":"Diabetes Care"},{"issue":"2","key":"959_CR18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3109\/03009742.2010.507218","volume":"40","author":"CF Kuo","year":"2011","unstructured":"Kuo CF, Luo SF, See LC, Ko YS, Chen YM, Hwang JS, Chou IJ, Chang HC, Chen HW, Yu KH. Hyperuricaemia and accelerated reduction in renal function. Scand J Rheumatol. 2011;40(2):116\u201321.","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"959_CR19","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1681\/ASN.2005091012","volume":"17","author":"A Ishani","year":"2006","unstructured":"Ishani A, Grandits GA, Grimm RH, Svendsen KH, Collins AJ, Prineas RJ, Neaton JD. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. J Am Soc Nephrol. 2006;17(5):1444\u201352.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"959_CR20","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1001\/archinternmed.2008.605","volume":"169","author":"CY Hsu","year":"2009","unstructured":"Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med. 2009;169(4):342\u201350.","journal-title":"Arch Intern Med"},{"issue":"8","key":"959_CR21","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1093\/ndt\/gfq740","volume":"26","author":"IZ Ben-Dov","year":"2011","unstructured":"Ben-Dov IZ, Kark JD. Serum uric acid is a GFR-independent long-term predictor of acute and chronic renal insufficiency: the Jerusalem lipid research clinic cohort study. Nephrol Dial Transplant. 2011;26(8):2558\u201366.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"959_CR22","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/S0272-6386(04)00934-5","volume":"44","author":"K Iseki","year":"2004","unstructured":"Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis. 2004;44(4):642\u201350.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"959_CR23","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s11255-007-9253-3","volume":"39","author":"M Kanbay","year":"2007","unstructured":"Kanbay M, Ozkara A, Selcoki Y, Isik B, Turgut F, Bavbek N, Uz E, Akcay A, Yigitoglu R, Covic A. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions. Int Urol Nephrol. 2007;39(4):1227\u201333.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"959_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1053\/j.ajkd.2005.10.006","volume":"47","author":"YP Siu","year":"2006","unstructured":"Siu YP, Leung KT, Tong MK, Kwan TH. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis. 2006;47(1):51\u20139.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"959_CR25","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.2215\/CJN.01580210","volume":"5","author":"M Goicoechea","year":"2010","unstructured":"Goicoechea M, de Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, Rincon A, Arroyo D, Luno J. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol. 2010;5(8):1388\u201393.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"959_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4103\/1118-8561.181890","volume":"19","author":"O Adejumo","year":"2016","unstructured":"Adejumo O, Okaka E, Okwuonu C, Ojogwu L. Hyperuricemia in predialysis chronic kidney disease patients in Southern Nigeria. Sahel Med J. 2016;19(1):21\u20136.","journal-title":"Sahel Med J"},{"key":"959_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4236\/ojneph.2017.71002","volume":"7","author":"G Mahamat Abderraman","year":"2017","unstructured":"Mahamat Abderraman G, Hamat I, Tondi Z, Lemrabott A, Faye M, Moustapha C, Sabi K, Ka K, Abdou N, Boucar D. Hyperuricemia in patients with chronic renal failure in the general hospital of national reference of N'Djamena (Chad). Open J Nephrol. 2017;7:9\u201318.","journal-title":"Open J Nephrol"},{"issue":"Suppl 5","key":"959_CR28","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.3949\/ccjm.75.Suppl_5.S13","volume":"75","author":"NL Edwards","year":"2008","unstructured":"Edwards NL. The role of hyperuricemia and gout in kidney and cardiovascular disease. Cleve Clin J Med. 2008;75(Suppl 5):S13\u20136.","journal-title":"Cleve Clin J Med"},{"issue":"5","key":"959_CR29","doi-asserted-by":"publisher","first-page":"e97646","DOI":"10.1371\/journal.pone.0097646","volume":"9","author":"B Stib\u016frkov\u00e1","year":"2014","unstructured":"Stib\u016frkov\u00e1 B, Pavl\u00edkov\u00e1 M, Sokolov\u00e1 J, Ko\u017eich V. Metabolic syndrome, alcohol consumption and genetic factors are associated with serum uric acid concentration. PLoS One. 2014;9(5):e97646.","journal-title":"PLoS One"},{"issue":"1","key":"959_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1758-5996-4-12","volume":"4","author":"EP de Oliveira","year":"2012","unstructured":"de Oliveira EP, Burini RC. High plasma uric acid concentration: causes and consequences. Diabetol Metab Syndr. 2012;4(1):12.","journal-title":"Diabetol Metab Syndr"},{"issue":"3","key":"959_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1089\/met.2009.0084","volume":"8","author":"R Villegas","year":"2010","unstructured":"Villegas R, Xiang Y-B, Cai Q, Fazio S, Linton M, Li H, Elasy T, Zheng W, Shu XO. Prevalence and determinants of hyperuricemia in middle-aged, urban Chinese men. Metab Syndr Relat Disord. 2010;8(3):263\u201370.","journal-title":"Metab Syndr Relat Disord"},{"issue":"5\u20136","key":"959_CR32","first-page":"1009","volume":"21","author":"J Chalmers","year":"1999","unstructured":"Chalmers J, MacMahon S, Mancia G, Whitworth J, Beilin L, Hansson L, Neal B, Rodgers A, Ni Mhurchu C, Clark T. 1999 World Health Organization-International Society of Hypertension Guidelienes for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens. 1999;21(5\u20136):1009\u201360.","journal-title":"Clin Exp Hypertens"},{"key":"959_CR33","doi-asserted-by":"publisher","first-page":"1):1","DOI":"10.1007\/s00604-008-0044-z","volume":"164","author":"Y Zhao","year":"2009","unstructured":"Zhao Y, Yang X, Lu W, Liao H, Liao F. Uricase based methods for determination of uric acid in serum. Microchim Acta. 2009;164:1):1\u20136.","journal-title":"Microchim Acta"},{"key":"959_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1373\/clinchem.2005.059055","volume":"52","author":"W Junge","year":"2006","unstructured":"Junge W, Wilke B, Halabi A, Jarausch J, Klein G. Reference intervals for total protein in collected and random urine using the Benzethonium chloride. Clin Chem. 2006;52:157.","journal-title":"Clin Chem"},{"key":"959_CR35","first-page":"53","volume":"46","author":"BC Mazzachi","year":"2000","unstructured":"Mazzachi BC, Peake MJ, Ehrhard V. Reference range and method comparison studies for enzymatic and Jaff\u00e9 cr\u00e9atinin assays in plasma and serum, and early morning urine. Clin Lab. 2000;46:53\u20135.","journal-title":"Clin Lab"},{"issue":"9","key":"959_CR36","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, AFr C, Feldman HI, KJ W, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate gloomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"11","key":"959_CR37","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"PE Stevens","year":"2013","unstructured":"Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825\u201330.","journal-title":"Ann Intern Med"},{"key":"959_CR38","volume-title":"Rheumatology","author":"MC Hochberg","year":"2003","unstructured":"Hochberg MC, Smolen JS, Weinblatt ME. Rheumatology. New York: Mosby; 2003."},{"issue":"3","key":"959_CR39","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/ije\/dyu058","volume":"43","author":"A Keys","year":"2014","unstructured":"Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL. Indices of relative weight and obesity. Int J Epidemiol. 2014;43(3):655\u201365.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"959_CR40","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1053\/j.seminhematol.2008.06.006","volume":"45","author":"KV Patel","year":"2008","unstructured":"Patel KV. Epidemiology of anemia in older adults. Semin Hematol. 2008;45(4):210\u20137.","journal-title":"Semin Hematol"},{"key":"959_CR41","doi-asserted-by":"crossref","unstructured":"Third Report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002;106(25):3143\u2013421.","DOI":"10.1161\/circ.106.25.3143"},{"issue":"1","key":"959_CR42","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jpeds.2012.06.008","volume":"162","author":"DG Noone","year":"2013","unstructured":"Noone DG, Marks SD. Hyperuricemia is associated with hypertension, obesity, and albuminuria in children with chronic kidney disease. J Pediatr. 2013;162(1):128\u201332.","journal-title":"J Pediatr"},{"issue":"11","key":"959_CR43","doi-asserted-by":"publisher","first-page":"e50046","DOI":"10.1371\/journal.pone.0050046","volume":"7","author":"E Krishnan","year":"2012","unstructured":"Krishnan E. Reduced glomerular function and prevalence of gout: NHANES 2009\u201310. PLoS One. 2012;7(11):e50046.","journal-title":"PLoS One"},{"issue":"3","key":"959_CR44","first-page":"305","volume":"8","author":"AM Kahn","year":"1988","unstructured":"Kahn AM. Effect of diuretics on the renal handling of urate. Semin Nephrol. 1988;8(3):305\u201314.","journal-title":"Semin Nephrol"},{"issue":"6","key":"959_CR45","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1161\/01.HYP.0000072820.07472.3B","volume":"41","author":"J Kanellis","year":"2003","unstructured":"Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, Wamsley A, Sheikh-Hamad D, Lan HY, Feng L, et al. Uric acid stimulates monocyte chemoattractant Protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and Cyclooxygenase-2. Hypertension. 2003;41(6):1287\u201393.","journal-title":"Hypertension"},{"issue":"6","key":"959_CR46","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1161\/01.HYP.0000248752.08807.4c","volume":"48","author":"TS Perlstein","year":"2006","unstructured":"Perlstein TS, Gumieniak O, Williams GH, Sparrow D, Vokonas PS, Gaziano M, Weiss ST, Litonjua AA. Uric Acid and the Development of Hypertension. The Normative Aging Study. Hypertension. 2006;48(6):1031\u20136.","journal-title":"Hypertension"},{"issue":"11","key":"959_CR47","doi-asserted-by":"publisher","first-page":"e76827","DOI":"10.1371\/journal.pone.0076827","volume":"8","author":"S Sedaghat","year":"2013","unstructured":"Sedaghat S, Hoorn EJ, van Rooij FJA, Hofman A, Franco OH, Witteman JCM, Dehghan A. Serum uric acid and chronic kidney disease: the role of hypertension. PLoS One. 2013;8(11):e76827.","journal-title":"PLoS One"},{"issue":"6","key":"959_CR48","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/S0272-6386(97)90106-2","volume":"30","author":"GM Reaven","year":"1997","unstructured":"Reaven GM. The kidney: an unwilling accomplice in syndrome X. Am J Kidney Dis. 1997;30(6):928\u201331.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"959_CR49","doi-asserted-by":"publisher","first-page":"R193","DOI":"10.1186\/ar4026","volume":"14","author":"MA McAdams-DeMarco","year":"2012","unstructured":"McAdams-DeMarco MA, Maynard JW, Coresh J, Baer AN. Anemia and the onset of gout in a population-based cohort of adults: atherosclerosis risk in communities study. Arthritis Res Ther. 2012;14(4):R193.","journal-title":"Arthritis Res Ther"},{"key":"959_CR50","doi-asserted-by":"crossref","unstructured":"Bergamini C, Cicoira M, Rossi A, Vassanelli C. Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure. Eur J Heart Fail. 2009;11(5):444\u201352.","DOI":"10.1093\/eurjhf\/hfp042"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-0959-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-018-0959-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-0959-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T19:11:11Z","timestamp":1562613071000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-018-0959-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,9]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["959"],"URL":"https:\/\/doi.org\/10.1186\/s12882-018-0959-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,9]]},"assertion":[{"value":"12 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We obtained ethical clearance from the Cameroon National Ethics Committee. Written consent was obtained from all patients to participate to All participants gave their consent to this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"169"}}